Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Metastatic Malignant Neoplasm in the Brain
Interventions: Other: Laboratory Biomarker Analysis; Other: Pharmacological Study; Other: Quality-of-Life Assessment; Drug: Ropidoxuridine; Radiation: Whole-Brain Radiotherapy
Sponsors: National Cancer Institute (NCI)
Active, not recruiting